Systematic Evolution Of Ligands By Exponential Enrichment: Photoselection Of Nucleic Acid Ligands

Kirk Jensen (Inventor)

Research output: Patent

Abstract

Methods to obtain nucleic acid ligands that photocrosslink to target molecules associated with a disease state are provided. The methods presented are variations on the photoSELEX methods for obtaining nucleic acid ligands. In one method, a candidate mixture of photocrosslinkable nucleic acids is contacted with a biological substance obtained from a source associated with a disease state suspected of containing a target molecule to form nucleic acid-target molecule complexes, the complexes are irradiated to form crosslinked complexes, the photocrosslinked complexes are partitioned from the remainder of the candidate mixture; and the nucleic acid ligands that photocrosslink to molecule are retained. These nucleic acids are then contacted with a second biological substance of the same type as the first, but obtained from a source not associated with a disease state. This removes nucleic acids with affinity to molecules that are not associated with the disease state. In another method, photocrosslinkable nucleic acids are not incorporated in the initial candidate mixture, but rather are incorporated in an enriched candidate mixture obtained by contacting a biological substance associated with a disease state containing a target molecule to form nucleic acid-target molecule complexes, partitioning the complexes away from the candidate mixture.
LanguageEnglish
Patent numberUS 6482594 B2
IPCUS 6482594 B2
Publication statusPublished - 19 Nov 2002

Cite this

Jensen, K. (2002). IPC No. US 6482594 B2. Systematic Evolution Of Ligands By Exponential Enrichment: Photoselection Of Nucleic Acid Ligands. (Patent No. US 6482594 B2). United States Patent & Trademark Office.
Jensen, Kirk (Inventor). / Systematic Evolution Of Ligands By Exponential Enrichment: Photoselection Of Nucleic Acid Ligands. United States Patent & Trademark Office. IPC No.: US 6482594 B2. Patent No.: US 6482594 B2.
@misc{30ff2fc2f5b04da7aea71c1271771722,
title = "Systematic Evolution Of Ligands By Exponential Enrichment: Photoselection Of Nucleic Acid Ligands",
abstract = "Methods to obtain nucleic acid ligands that photocrosslink to target molecules associated with a disease state are provided. The methods presented are variations on the photoSELEX methods for obtaining nucleic acid ligands. In one method, a candidate mixture of photocrosslinkable nucleic acids is contacted with a biological substance obtained from a source associated with a disease state suspected of containing a target molecule to form nucleic acid-target molecule complexes, the complexes are irradiated to form crosslinked complexes, the photocrosslinked complexes are partitioned from the remainder of the candidate mixture; and the nucleic acid ligands that photocrosslink to molecule are retained. These nucleic acids are then contacted with a second biological substance of the same type as the first, but obtained from a source not associated with a disease state. This removes nucleic acids with affinity to molecules that are not associated with the disease state. In another method, photocrosslinkable nucleic acids are not incorporated in the initial candidate mixture, but rather are incorporated in an enriched candidate mixture obtained by contacting a biological substance associated with a disease state containing a target molecule to form nucleic acid-target molecule complexes, partitioning the complexes away from the candidate mixture.",
author = "Kirk Jensen",
year = "2002",
month = "11",
day = "19",
language = "English",
publisher = "United States Patent & Trademark Office",
type = "Patent",
note = "US 6482594 B2; US 6482594 B2",

}

Systematic Evolution Of Ligands By Exponential Enrichment: Photoselection Of Nucleic Acid Ligands. / Jensen, Kirk (Inventor).

United States Patent & Trademark Office. IPC No.: US 6482594 B2. Patent No.: US 6482594 B2.

Research output: Patent

TY - PAT

T1 - Systematic Evolution Of Ligands By Exponential Enrichment: Photoselection Of Nucleic Acid Ligands

AU - Jensen, Kirk

PY - 2002/11/19

Y1 - 2002/11/19

N2 - Methods to obtain nucleic acid ligands that photocrosslink to target molecules associated with a disease state are provided. The methods presented are variations on the photoSELEX methods for obtaining nucleic acid ligands. In one method, a candidate mixture of photocrosslinkable nucleic acids is contacted with a biological substance obtained from a source associated with a disease state suspected of containing a target molecule to form nucleic acid-target molecule complexes, the complexes are irradiated to form crosslinked complexes, the photocrosslinked complexes are partitioned from the remainder of the candidate mixture; and the nucleic acid ligands that photocrosslink to molecule are retained. These nucleic acids are then contacted with a second biological substance of the same type as the first, but obtained from a source not associated with a disease state. This removes nucleic acids with affinity to molecules that are not associated with the disease state. In another method, photocrosslinkable nucleic acids are not incorporated in the initial candidate mixture, but rather are incorporated in an enriched candidate mixture obtained by contacting a biological substance associated with a disease state containing a target molecule to form nucleic acid-target molecule complexes, partitioning the complexes away from the candidate mixture.

AB - Methods to obtain nucleic acid ligands that photocrosslink to target molecules associated with a disease state are provided. The methods presented are variations on the photoSELEX methods for obtaining nucleic acid ligands. In one method, a candidate mixture of photocrosslinkable nucleic acids is contacted with a biological substance obtained from a source associated with a disease state suspected of containing a target molecule to form nucleic acid-target molecule complexes, the complexes are irradiated to form crosslinked complexes, the photocrosslinked complexes are partitioned from the remainder of the candidate mixture; and the nucleic acid ligands that photocrosslink to molecule are retained. These nucleic acids are then contacted with a second biological substance of the same type as the first, but obtained from a source not associated with a disease state. This removes nucleic acids with affinity to molecules that are not associated with the disease state. In another method, photocrosslinkable nucleic acids are not incorporated in the initial candidate mixture, but rather are incorporated in an enriched candidate mixture obtained by contacting a biological substance associated with a disease state containing a target molecule to form nucleic acid-target molecule complexes, partitioning the complexes away from the candidate mixture.

M3 - Patent

M1 - US 6482594 B2

PB - United States Patent & Trademark Office

ER -